Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 1, Pages 141
Publisher
Baishideng Publishing Group Inc.
Online
2017-01-05
DOI
10.3748/wjg.v23.i1.141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice
- (2015) TAKUMI ONOYAMA et al. Molecular Medicine Reports
- Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease
- (2014) Alessandro Federico WORLD JOURNAL OF GASTROENTEROLOGY
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease
- (2013) Yasuji Arase et al. HEPATOLOGY RESEARCH
- Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
- (2013) Selvihan Beysel Akaslan et al. Metabolic Syndrome and Related Disorders
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Sitagliptin: Anti-platelet effect in diabetes and healthy volunteers
- (2012) Ashish Kumar Gupta et al. PLATELETS
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
- (2011) Tomoyuki Iwasaki et al. HEPATO-GASTROENTEROLOGY
- Evaluation of adipose tissue volume quantification with IDEAL fat-water separation
- (2011) Abdullah Alabousi et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Quantification of Hepatic Steatosis with T1-independent, T2*-corrected MR Imaging with Spectral Modeling of Fat: Blinded Comparison with MR Spectroscopy
- (2011) Sina Meisamy et al. RADIOLOGY
- Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats
- (2010) Bárbara Maiztegui et al. CLINICAL SCIENCE
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
- (2010) Shani Ben-Shlomo et al. JOURNAL OF HEPATOLOGY
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
- (2010) Gábor Firneisz et al. PLoS One
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Quantification of hepatic steatosis with MRI: The effects of accurate fat spectral modeling
- (2009) Scott B. Reeder et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- T1independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: Validation in a fat-water-SPIO phantom
- (2009) Catherine D.G. Hines et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Quantification of Hepatic Steatosis with 3-T MR Imaging: Validation inob/obMice
- (2009) Catherine D. G. Hines et al. RADIOLOGY
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
- (2008) Debora Williams-Herman et al. BMC Endocrine Disorders
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search